Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
PLF(+)(n = 37) | PLF(−)(n = 210) | p | Exp(B) | OR95%CI | p | |
Age (years) | 54.9 ± 10.9 | 53.0 ± 10.2 | 0.286 | |||
Gender (Male /Female) | 33/4 (89%/11%) | 180/30 (86%/14%) | 0.572 | |||
BMI (kg /m2) | 23.7 ± 3.1 | 23.3 ± 3.0 | 0.423 | |||
White blood cell (109/l) | 4.9 ± 1.5 | 5.3 ± 2.1 | 0.275 | |||
Hemoglobin (g/l) | 144.2 ± 12.3 | 143.8 ± 14.4 | 0.881 | |||
Platelet Count (109/l) | 139.0 ± 79.9 | 155.3 ± 56.9 | 0.037 | |||
Total bilirubin (umol/l) | 19.1 ± 8.8 | 15.4 ± 12.2 | 0.079 | |||
Albumin (g/l) | 41.0 ± 3.6 | 41.9 ± 3.2 | 0.123 | |||
Prealbumin (mg/l) | 218.2 ± 67.9 | 242.2 ± 61.0 | 0.032 | |||
Alanine transaminase (u/l) | 43.2 ± 31.3 | 38.5 ± 34.7 | 0.449 | |||
Aspartate aminotransferase (u/l) | 41.2 ± 23 | 36.1 ± 32.4 | 0.366 | |||
Gamma-glutamyl transpeptidase (u/l) | 104.8 ± 148.6 | 68.6 ± 69.2 | 0.027 | |||
Alkaline phosphatase (u/l) | 100.0 ± 47.4 | 83.2 ± 23.3 | 0.173 | |||
PT(s) | 12.1 ± 1.2 | 11.6 ± 0.8 | 0.005 | |||
INR | 1.0 ± 0.1 | 1.0 ± 0.1 | 0.005 | 1.065 | 1.014–1.119 | 0.013 |
APTT(s) | 28.9 ± 5.9 | 27.1 ± 5.2 | 0.067 | |||
LSM(kpa) | 21.4 ± 6.3 | 12.7 ± 5.7 | <0.001 | 1.211 | 1.134–1.293 | <0.001 |
Intraoperative blood infusion (yes /no) | 7/30 (18.9%/81.1%) | 12/198 (5.7%/94.3%) | 0.005 | |||
Portal vein occlusion (yes/no) | 24/13 (64.9%/35.1%) | 160/50 (76.2%/23.8%) | 0.145 | |||
Number of tumors (Single/multiple) | 32/5 (86.5%/13.5%) | 185/25 (88.1%/11.9%) | 0.782 | |||
Tumor capsule (yes/no) | 24/13 (64.9%/35.1%) | 150/60 (71.4%/28.6%) | 0.420 | |||
HBV DNA levels (>1.0E + 04iu/ml/<1.0E + 04iu/ml) | 13/24 (35.1%/64.9%) | 60/150 (28.6%/71.4%) | 0.422 | |||
Cirrhosis (yes/no) | 22/15 (59.5%/40.5%) | 54/156 (27.7%/74.3%) | <0. 001 | |||
Esophageal varices (yes/no) | 7/30 (18.9%/81.1%) | 11/199 (5.2%/94.8%) | 0.003 | |||
Major hepatectomy | 8 (22%) | 32 (15%) | 0.331 | |||
Median main tumor size (cm) | 5.6 ± 4.0 | 4.9 ± 3 | 0.687 | |||
Tumor location (right lobe/left lobe/both) | 29/6/2 (78.4%/16.2%/5.4%) | 129/73/8 (61.4%/34.8%/3.8%) | 0.082 |